Cite
HARVARD Citation
Idzior-Waluś, B. et al. (2016). Apo-B48 in patients with type 2 diabetes and non-alkoholic fatty liver disease. Atherosclerosis. pp. e153-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Idzior-Waluś, B. et al. (2016). Apo-B48 in patients with type 2 diabetes and non-alkoholic fatty liver disease. Atherosclerosis. pp. e153-. [Online].